Persistent moderate methylmalonic aciduria in a patient with methylmalonyl CoA epimerase deficiency

Turk J Pediatr. 2022;64(5):946-950. doi: 10.24953/turkjped.2021.245.

Abstract

Background: Methylmalonyl CoA epimerase (MCE) deficiency was first reported in 2006 and only a few cases have been reported so far. The clinical spectrum of MCE deficiency ranges from asymptomatic to lifethreatening metabolic decompensation attacks.

Case: Herein we report a patient diagnosed with MCE deficiency with recurrent acute metabolic ketoacidosis attacks and moderate MMA-uria that persisted in periods without decompensation. At presentation, organic acid profiles were dominated by increased 3 hydroxybutyrate.

Conclusions: 3-Oxothiolase deficiency as a main ketolysis defects disorder was initially suspected. However, the subsequently repeated organic acid analyses demonstrated mild and persistent elevation of methylmalonic acid. This report provides a new phenotype of the clinical and biochemical characterization of MCE deficiency.

Keywords: ketosis; methylmalonic aciduria; methylmalonyl-CoA epimerase.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Metabolism, Inborn Errors* / complications
  • Amino Acid Metabolism, Inborn Errors* / diagnosis
  • Humans
  • Racemases and Epimerases / genetics

Substances

  • methylmalonyl-coenzyme A
  • Racemases and Epimerases

Supplementary concepts

  • Methylmalonic acidemia
  • Methylmalonyl-CoA Epimerase Deficiency